Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Althea Group is an early-stage investment firm based in New York, founded to focus on genetic medicine and other innovative technologies. The firm provides growth capital and strategic advisory services to help develop next-generation solutions in healthcare. Althea Group operates with a hands-on operator model, emphasizing support for companies pioneering advancements in genetic therapies, cancer treatment, women's health, and digestive health.
Currently, Althea Group manages a portfolio of 12 companies, with a concentrated investment strategy that spans various sectors, including biotech, healthcare, AI, fintech, and consumer goods. The firm has not publicly disclosed its fund size but is known for its active engagement in the early-stage investment landscape. Althea Group's notable milestone includes the acquisition of its portfolio company, RxTransparent, by Inmar Intelligence, a portfolio company of OMERS.
Althea Group primarily invests in early-stage companies, focusing on sectors such as genetic medicine, cancer therapy, women's health, and digestive health. Their investment strategy encompasses seed and pre-seed funding, targeting technologies that promise safe and effective healthcare solutions. The firm seeks to partner with companies that are developing innovative approaches to healthcare challenges, particularly in genetic therapies and diagnostics.
The check size for investments typically ranges from $100,000 to $5 million, with a sweet spot around $1.5 million. Althea Group maintains a geographic focus on the United States, particularly New York, while leveraging a global network for biotech investments. The firm looks for founders who demonstrate a strong vision and commitment to advancing healthcare technologies.
Althea Group's portfolio includes a diverse range of companies, reflecting its focus on innovative healthcare solutions:
To pitch Althea Group, founders should send an email to info@altheagroup.com. A well-structured pitch deck is essential, including details about the business model, market opportunity, and team. Althea Group appreciates concise presentations that clearly outline the technology's impact on healthcare.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred but not required.
What are Althea Group's investment criteria?
Althea Group invests in early-stage companies primarily in the sectors of genetic medicine, cancer therapy, women's health, and digestive health. They focus on technologies that promise safe and effective healthcare solutions.
How can I apply or pitch to Althea Group?
Founders can reach out to Althea Group via email at info@altheagroup.com to discuss potential investment opportunities. A detailed pitch deck outlining the business model, market opportunity, and team is recommended.
What makes Althea Group different from other VC firms?
Althea Group employs a hands-on operator model, providing not only capital but also strategic advisory services to help portfolio companies navigate early-stage growth challenges.
What is the geographic scope of Althea Group's investments?
While based in New York, Althea Group has a global network for biotech investments, allowing them to consider opportunities beyond the U.S.
What is the typical check size for investments?
Althea Group typically invests between $100,000 and $5 million, with a sweet spot around $1.5 million for early-stage companies.
What kind of post-investment involvement does Althea Group have?
Althea Group provides hands-on support and strategic advisory services to its portfolio companies, helping them navigate the complexities of early-stage growth and development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.